Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Is fibroblast growth factor signaling pathway a victim of receptor tyrosine kinase inhibition in pulmonary parenchymal and vascular remodeling?

El Agha E, Schwind F, Ruppert C, Günther A, Bellusci S, Schermuly RT, Kosanovic D.

Am J Physiol Lung Cell Mol Physiol. 2018 May 3. doi: 10.1152/ajplung.00140.2018. [Epub ahead of print]

PMID:
29722558
2.

The value of short-term pain relief in predicting the long-term outcome of 'indirect' cervical epidural steroid injections.

Joswig H, Neff A, Ruppert C, Hildebrandt G, Stienen MN.

Acta Neurochir (Wien). 2018 May;160(5):935-943. doi: 10.1007/s00701-018-3511-2. Epub 2018 Mar 14.

PMID:
29541886
3.

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis.

Al-Tamari HM, Dabral S, Schmall A, Sarvari P, Ruppert C, Paik J, DePinho RA, Grimminger F, Eickelberg O, Guenther A, Seeger W, Savai R, Pullamsetti SS.

EMBO Mol Med. 2018 Feb;10(2):276-293. doi: 10.15252/emmm.201606261.

4.

The Value of Short-Term Pain Relief in Predicting the Long-Term Outcome of Lumbar Transforaminal Epidural Steroid Injections.

Joswig H, Neff A, Ruppert C, Hildebrandt G, Stienen MN.

World Neurosurg. 2017 Nov;107:764-771. doi: 10.1016/j.wneu.2017.08.055. Epub 2017 Aug 23.

PMID:
28838872
5.

Surfactant replacement therapy reduces acute lung injury and collapse induration-related lung remodeling in the bleomycin model.

Steffen L, Ruppert C, Hoymann HG, Funke M, Ebener S, Kloth C, Mühlfeld C, Ochs M, Knudsen L, Lopez-Rodriguez E.

Am J Physiol Lung Cell Mol Physiol. 2017 Aug 1;313(2):L313-L327. doi: 10.1152/ajplung.00033.2017. Epub 2017 Apr 27.

PMID:
28450283
6.

Surfactant inhibits ATP-induced release of interleukin-1β via nicotinic acetylcholine receptors.

Backhaus S, Zakrzewicz A, Richter K, Damm J, Wilker S, Fuchs-Moll G, Küllmar M, Hecker A, Manzini I, Ruppert C, McIntosh JM, Padberg W, Grau V.

J Lipid Res. 2017 Jun;58(6):1055-1066. doi: 10.1194/jlr.M071506. Epub 2017 Apr 12.

7.

The Role of Electronic and Phononic Excitation in the Optical Response of Monolayer WS2 after Ultrafast Excitation.

Ruppert C, Chernikov A, Hill HM, Rigosi AF, Heinz TF.

Nano Lett. 2017 Feb 8;17(2):644-651. doi: 10.1021/acs.nanolett.6b03513. Epub 2017 Jan 11.

PMID:
28059520
8.

Tissue remodelling in pulmonary fibrosis.

Knudsen L, Ruppert C, Ochs M.

Cell Tissue Res. 2017 Mar;367(3):607-626. doi: 10.1007/s00441-016-2543-2. Epub 2016 Dec 16. Review.

PMID:
27981380
9.

The value of short-term pain relief in predicting the 1-month outcome of 'indirect' cervical epidural steroid injections.

Joswig H, Neff A, Ruppert C, Hildebrandt G, Stienen MN.

Acta Neurochir (Wien). 2017 Feb;159(2):291-300. doi: 10.1007/s00701-016-2997-8. Epub 2016 Oct 28.

PMID:
27796650
10.

The Value of Short-Term Pain Relief in Predicting the One-Month Outcome of Lumbar Transforaminal Epidural Steroid Injections.

Joswig H, Neff A, Ruppert C, Hildebrandt G, Stienen MN.

World Neurosurg. 2016 Dec;96:323-333. doi: 10.1016/j.wneu.2016.09.016. Epub 2016 Sep 15.

PMID:
27641258
11.

Regulation of macroautophagy in amiodarone-induced pulmonary fibrosis.

Mahavadi P, Knudsen L, Venkatesan S, Henneke I, Hegermann J, Wrede C, Ochs M, Ahuja S, Chillappagari S, Ruppert C, Seeger W, Korfei M, Guenther A.

J Pathol Clin Res. 2015 Jun 3;1(4):252-63. doi: 10.1002/cjp2.20. eCollection 2015 Oct.

12.

Thermochromic modulation of surface plasmon polaritons in vanadium dioxide nanocomposites.

Jostmeier T, Mangold M, Zimmer J, Karl H, Krenner HJ, Ruppert C, Betz M.

Opt Express. 2016 Jul 25;24(15):17321-31. doi: 10.1364/OE.24.017321.

PMID:
27464181
13.

Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells.

Göbel K, Pankratz S, Asaridou CM, Herrmann AM, Bittner S, Merker M, Ruck T, Glumm S, Langhauser F, Kraft P, Krug TF, Breuer J, Herold M, Gross CC, Beckmann D, Korb-Pap A, Schuhmann MK, Kuerten S, Mitroulis I, Ruppert C, Nolte MW, Panousis C, Klotz L, Kehrel B, Korn T, Langer HF, Pap T, Nieswandt B, Wiendl H, Chavakis T, Kleinschnitz C, Meuth SG.

Nat Commun. 2016 May 18;7:11626. doi: 10.1038/ncomms11626.

14.

MAP1LC3B overexpression protects against Hermansky-Pudlak syndrome type-1-induced defective autophagy in vitro.

Ahuja S, Knudsen L, Chillappagari S, Henneke I, Ruppert C, Korfei M, Gochuico BR, Bellusci S, Seeger W, Ochs M, Guenther A, Mahavadi P.

Am J Physiol Lung Cell Mol Physiol. 2016 Mar 15;310(6):L519-31. doi: 10.1152/ajplung.00213.2015. Epub 2015 Dec 30.

15.

Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.

Korfei M, Skwarna S, Henneke I, MacKenzie B, Klymenko O, Saito S, Ruppert C, von der Beck D, Mahavadi P, Klepetko W, Bellusci S, Crestani B, Pullamsetti SS, Fink L, Seeger W, Krämer OH, Guenther A.

Thorax. 2015 Nov;70(11):1022-32. doi: 10.1136/thoraxjnl-2014-206411. Epub 2015 Sep 10.

PMID:
26359372
16.

Differences in natural history of low- and high-gradient aortic stenosis from nonsevere to severe stage of the disease.

Herrmann S, Fries B, Liu D, Hu K, Stoerk S, Voelker W, Ruppert C, Lorenz K, Ertl G, Weidemann F.

J Am Soc Echocardiogr. 2015 Nov;28(11):1270-1282.e4. doi: 10.1016/j.echo.2015.07.016. Epub 2015 Aug 28.

PMID:
26321001
17.

Regulation of immunoproteasome function in the lung.

Keller IE, Vosyka O, Takenaka S, Kloß A, Dahlmann B, Willems LI, Verdoes M, Overkleeft HS, Marcos E, Adnot S, Hauck SM, Ruppert C, Günther A, Herold S, Ohno S, Adler H, Eickelberg O, Meiners S.

Sci Rep. 2015 May 19;5:10230. doi: 10.1038/srep10230.

18.

Linking progression of fibrotic lung remodeling and ultrastructural alterations of alveolar epithelial type II cells in the amiodarone mouse model.

Birkelbach B, Lutz D, Ruppert C, Henneke I, Lopez-Rodriguez E, Günther A, Ochs M, Mahavadi P, Knudsen L.

Am J Physiol Lung Cell Mol Physiol. 2015 Jul 1;309(1):L63-75. doi: 10.1152/ajplung.00279.2014. Epub 2015 May 8.

19.

Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.

Oruqaj G, Karnati S, Vijayan V, Kotarkonda LK, Boateng E, Zhang W, Ruppert C, Günther A, Shi W, Baumgart-Vogt E.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):E2048-57. doi: 10.1073/pnas.1415111112. Epub 2015 Apr 6.

20.

Optical properties and band gap of single- and few-layer MoTe2 crystals.

Ruppert C, Aslan OB, Heinz TF.

Nano Lett. 2014 Nov 12;14(11):6231-6. doi: 10.1021/nl502557g. Epub 2014 Oct 29.

PMID:
25302768
21.

Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone-induced lung fibrosis.

Mahavadi P, Henneke I, Ruppert C, Knudsen L, Venkatesan S, Liebisch G, Chambers RC, Ochs M, Schmitz G, Vancheri C, Seeger W, Korfei M, Guenther A.

Toxicol Sci. 2014 Nov;142(1):285-97. doi: 10.1093/toxsci/kfu177. Epub 2014 Aug 27.

PMID:
25163675
22.

Georg Büchner, Sigmund Freud and the "Schädelnerven" (cranial nerves) - research on the brain and soul in the 19th century.

Hildebrandt G, Ruppert C, Stienen MN, Surbeck W.

Acta Neurochir (Wien). 2014 Oct;156(10):1999-2014. doi: 10.1007/s00701-014-2198-2. Epub 2014 Aug 14.

PMID:
25119305
23.

Biophysical inhibition of pulmonary surfactant function by polymeric nanoparticles: role of surfactant protein B and C.

Beck-Broichsitter M, Ruppert C, Schmehl T, Günther A, Seeger W.

Acta Biomater. 2014 Nov;10(11):4678-4684. doi: 10.1016/j.actbio.2014.07.026. Epub 2014 Aug 1.

PMID:
25087869
24.

Alveolar derecruitment and collapse induration as crucial mechanisms in lung injury and fibrosis.

Lutz D, Gazdhar A, Lopez-Rodriguez E, Ruppert C, Mahavadi P, Günther A, Klepetko W, Bates JH, Smith B, Geiser T, Ochs M, Knudsen L.

Am J Respir Cell Mol Biol. 2015 Feb;52(2):232-43. doi: 10.1165/rcmb.2014-0078OC.

PMID:
25033427
25.

Phase-retrieval of femtosecond pulses utilizing ω/2ω quantum interference control of electrical currents.

Sternemann E, Betz M, Ruppert C.

Opt Lett. 2014 Jun 15;39(12):3654-7. doi: 10.1364/OL.39.003654.

PMID:
24978560
26.

Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.

Beck-Broichsitter M, Ruppert C, Schmehl T, Günther A, Seeger W.

Biochim Biophys Acta. 2014 Jan;1838(1 Pt B):474-81. doi: 10.1016/j.bbamem.2013.10.016. Epub 2013 Nov 1.

27.

Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis.

Nkyimbeng T, Ruppert C, Shiomi T, Dahal B, Lang G, Seeger W, Okada Y, D'Armiento J, Günther A.

PLoS One. 2013 Sep 2;8(9):e73279. doi: 10.1371/journal.pone.0073279. eCollection 2013.

28.

Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors.

Korfei M, von der Beck D, Henneke I, Markart P, Ruppert C, Mahavadi P, Ghanim B, Klepetko W, Fink L, Meiners S, Krämer OH, Seeger W, Vancheri C, Guenther A.

J Proteomics. 2013 Jun 24;85:109-28. doi: 10.1016/j.jprot.2013.04.033. Epub 2013 May 6.

29.

Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy.

Ruppert C, Deiss K, Herrmann S, Vidal M, Oezkur M, Gorski A, Weidemann F, Lohse MJ, Lorenz K.

Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7440-5. doi: 10.1073/pnas.1221999110. Epub 2013 Apr 15.

30.

Ultrafast field-resolved semiconductor spectroscopy utilizing quantum interference control of currents.

Ruppert C, Lohrenz J, Thunich S, Betz M.

Opt Lett. 2012 Sep 15;37(18):3879-81. doi: 10.1364/OL.37.003879.

PMID:
23041890
31.

Electrical control of interdot electron tunneling in a double InGaAs quantum-dot nanostructure.

Müller K, Bechtold A, Ruppert C, Zecherle M, Reithmaier G, Bichler M, Krenner HJ, Abstreiter G, Holleitner AW, Villas-Boas JM, Betz M, Finley JJ.

Phys Rev Lett. 2012 May 11;108(19):197402. Epub 2012 May 8.

PMID:
23003087
32.

Cancer cachexia alters intracellular surfactant metabolism but not total alveolar surface area.

Graulich T, Das SK, Krasteva G, Ruppert C, Wessels L, Hoefler G, Mühlfeld C.

Histochem Cell Biol. 2012 Nov;138(5):803-13. doi: 10.1007/s00418-012-0995-3. Epub 2012 Jul 19.

PMID:
22810848
33.

Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis.

Günther A, Korfei M, Mahavadi P, von der Beck D, Ruppert C, Markart P.

Eur Respir Rev. 2012 Jun 1;21(124):152-60. doi: 10.1183/09059180.00001012. Review.

34.

Field-resolved characterization of femtosecond electromagnetic pulses with 400 THz bandwidth.

Thunich S, Ruppert C, Holleitner AW, Betz M.

Opt Lett. 2011 May 15;36(10):1791-3. doi: 10.1364/OL.36.001791.

PMID:
21593892
35.

Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs.

Korfei M, Schmitt S, Ruppert C, Henneke I, Markart P, Loeh B, Mahavadi P, Wygrecka M, Klepetko W, Fink L, Bonniaud P, Preissner KT, Lochnit G, Schaefer L, Seeger W, Guenther A.

J Proteome Res. 2011 May 6;10(5):2185-205. doi: 10.1021/pr1009355. Epub 2011 Mar 29.

PMID:
21319792
36.

Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury.

Spragg RG, Taut FJ, Lewis JF, Schenk P, Ruppert C, Dean N, Krell K, Karabinis A, Günther A.

Am J Respir Crit Care Med. 2011 Apr 15;183(8):1055-61. doi: 10.1164/rccm.201009-1424OC. Epub 2010 Dec 10.

PMID:
21148720
37.

Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro.

Beck-Broichsitter M, Ruppert C, Schmehl T, Guenther A, Betz T, Bakowsky U, Seeger W, Kissel T, Gessler T.

Nanomedicine. 2011 Jun;7(3):341-50. doi: 10.1016/j.nano.2010.10.007. Epub 2010 Nov 6.

PMID:
21059405
38.

Dry powder aerosolization of a recombinant surfactant protein-C-based surfactant for inhalative treatment of the acutely inflamed lung.

Ruppert C, Kuchenbuch T, Boensch M, Schmidt S, Mathes U, Hillebrand V, Henneke I, Markart P, Reiss I, Schermuly RT, Seeger W, Günther A.

Crit Care Med. 2010 Jul;38(7):1584-91. doi: 10.1097/CCM.0b013e3181dfcb3b.

PMID:
20400897
39.

Epithelial stress and apoptosis underlie Hermansky-Pudlak syndrome-associated interstitial pneumonia.

Mahavadi P, Korfei M, Henneke I, Liebisch G, Schmitz G, Gochuico BR, Markart P, Bellusci S, Seeger W, Ruppert C, Guenther A.

Am J Respir Crit Care Med. 2010 Jul 15;182(2):207-19. doi: 10.1164/rccm.200909-1414OC. Epub 2010 Apr 8.

40.

Quantum interference control of femtosecond, microA current bursts in single GaAs nanowires.

Ruppert C, Thunich S, Abstreiter G, Fontcuberta i Morral A, Holleitner AW, Betz M.

Nano Lett. 2010 May 12;10(5):1799-804. doi: 10.1021/nl1004898.

PMID:
20373775
41.

Induction of tissue factor by urokinase in lung epithelial cells and in the lungs.

Shetty S, Bhandary YP, Shetty SK, Velusamy T, Shetty P, Bdeir K, Gyetko MR, Cines DB, Idell S, Neuenschwander PF, Ruppert C, Guenther A, Abraham E, Shetty RS.

Am J Respir Crit Care Med. 2010 Jun 15;181(12):1355-66. doi: 10.1164/rccm.200901-0015OC. Epub 2010 Mar 1.

42.

Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis.

Markart P, Nass R, Ruppert C, Hundack L, Wygrecka M, Korfei M, Boedeker RH, Staehler G, Kroll H, Scheuch G, Seeger W, Guenther A.

J Aerosol Med Pulm Drug Deliv. 2010 Jun;23(3):161-72. doi: 10.1089/jamp.2009.0780.

PMID:
20109123
43.

Inhibition of urokinase activity reduces primary tumor growth and metastasis formation in a murine lung carcinoma model.

Henneke I, Greschus S, Savai R, Korfei M, Markart P, Mahavadi P, Schermuly RT, Wygrecka M, Stürzebecher J, Seeger W, Günther A, Ruppert C.

Am J Respir Crit Care Med. 2010 Mar 15;181(6):611-9. doi: 10.1164/rccm.200903-0342OC. Epub 2010 Jan 7.

PMID:
20056905
44.

Recombinant production of a hybrid plasminogen activator composed of surfactant protein B and low-molecular-weight urokinase.

Ruppert C, Mahavadi P, Wygrecka M, Weaver TE, Magdolen V, Idell S, Preissner KT, Seeger W, Günther A, Markart P.

Thromb Haemost. 2008 Dec;100(6):1185-92.

PMID:
19132247
45.

Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases.

Markart P, Luboeinski T, Korfei M, Schmidt R, Wygrecka M, Mahavadi P, Mayer K, Wilhelm J, Seeger W, Guenther A, Ruppert C.

Antioxid Redox Signal. 2009 Feb;11(2):227-40. doi: 10.1089/ARS.2008.2105.

PMID:
18783310
46.

Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis.

Korfei M, Ruppert C, Mahavadi P, Henneke I, Markart P, Koch M, Lang G, Fink L, Bohle RM, Seeger W, Weaver TE, Guenther A.

Am J Respir Crit Care Med. 2008 Oct 15;178(8):838-46. doi: 10.1164/rccm.200802-313OC. Epub 2008 Jul 17.

47.

Surfactant replacement and open lung concept--comparison of two treatment strategies in an experimental model of neonatal ARDS.

Hilgendorff A, Aslan E, Schaible T, Gortner L, Baehner T, Ebsen M, Kreuder J, Ruppert C, Guenther A, Reiss I.

BMC Pulm Med. 2008 Jul 14;8:10. doi: 10.1186/1471-2466-8-10.

48.
49.

Role of coagulation and fibrinolysis in lung and renal fibrosis.

Ruppert C, Markart P, Wygrecka M, Preissner KT, Günther A.

Hamostaseologie. 2008 Feb;28(1-2):30-2, 34-6. Review.

PMID:
18278159
50.

Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts.

Sadovski J, Kuchenbuch T, Ruppert C, Fehrenbach A, Hirschburger M, Padberg W, Günther A, Hohlfeld JM, Fehrenbach H, Grau V.

Eur Respir J. 2008 Jan;31(1):21-8. Epub 2007 Oct 10.

Supplemental Content

Loading ...
Support Center